PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.31%
Revenue growth at 50-75% of BIDU's 26.21%. Martin Whitman would worry about competitiveness or product relevance.
19.46%
Gross profit growth at 50-75% of BIDU's 31.54%. Martin Whitman would question if cost structure or brand is lagging.
29.30%
EBIT growth 50-75% of BIDU's 49.91%. Martin Whitman would suspect suboptimal resource allocation.
29.30%
Operating income growth at 50-75% of BIDU's 49.91%. Martin Whitman would doubt the firm’s ability to compete efficiently.
23.32%
Net income growth at 50-75% of BIDU's 39.90%. Martin Whitman would question fundamental disadvantages in expenses or demand.
24.00%
EPS growth at 50-75% of BIDU's 40.00%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
20.00%
Diluted EPS growth under 50% of BIDU's 40.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.32%
Share count expansion well above BIDU's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.23%
Diluted share count expanding well above BIDU's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
4.36%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-5.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
206.53%
10Y revenue/share CAGR under 50% of BIDU's 12749.51%. Michael Burry would suspect a lasting competitive disadvantage.
206.53%
5Y revenue/share CAGR under 50% of BIDU's 977.20%. Michael Burry would suspect a significant competitive gap or product weakness.
206.53%
3Y revenue/share CAGR at 75-90% of BIDU's 249.34%. Bill Ackman would expect new product strategies to close the gap.
880.04%
OCF/share CAGR of 880.04% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
880.04%
OCF/share CAGR of 880.04% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
880.04%
3Y OCF/share CAGR of 880.04% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
209.54%
Below 50% of BIDU's 37053.40%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
209.54%
Below 50% of BIDU's 812.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
209.54%
3Y net income/share CAGR above 1.5x BIDU's 116.21%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.29%
AR growth well above BIDU's 23.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
9.15%
Asset growth at 50-75% of BIDU's 16.42%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
9.27%
Similar to BIDU's 9.46%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-16.84%
We’re deleveraging while BIDU stands at 34.60%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
8.13%
R&D dropping or stable vs. BIDU's 36.08%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
8.82%
SG&A growth well above BIDU's 6.97%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.